scholarly article | Q13442814 |
P50 | author | Olha Ilnytska | Q79386768 |
P2093 | author name string | John T Groves | |
Pal Pacher | |||
Valeriy V Lyzogubov | |||
Irina G Obrosova | |||
Viktor R Drel | |||
Ivan A Pavlov | |||
Igor Vareniuk | |||
Seth R Bell | |||
P2860 | cites work | Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy | Q44779266 |
Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients | Q44903849 | ||
Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy | Q45034117 | ||
Quantitative measurement of cutaneous perception in diabetic neuropathy | Q45083878 | ||
Effects of the peroxynitrite decomposition catalyst, FeTMPyP, on function of corpus cavernosum from diabetic mice. | Q45089183 | ||
Remote neurotrophic support of epidermal nerve fibres in experimental diabetes | Q46984086 | ||
Telmisartan Shows an Equivalent Effect of Vitamin C in Further Improving Endothelial Dysfunction After Glycemia Normalization in Type 1 Diabetes | Q58829113 | ||
Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group | Q73905002 | ||
Effects of 15-month aldose reductase inhibition with fidarestat on the experimental diabetic neuropathy in rats | Q74228997 | ||
Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage | Q79801090 | ||
C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats | Q80049931 | ||
Nitric oxide and peroxynitrite in health and disease | Q24645400 | ||
Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor | Q29619105 | ||
Pioglitazone treatment improves nitrosative stress in type 2 diabetes | Q33237797 | ||
Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia | Q34017468 | ||
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. | Q34446867 | ||
Update on the pathogenesis of diabetic neuropathy | Q35581275 | ||
Poly(ADP-ribose) (PAR) polymer is a death signal | Q35722332 | ||
Neurotrophic modulation of myelinated cutaneous innervation and mechanical sensory loss in diabetic mice | Q35754093 | ||
Diabetic neuropathies: a statement by the American Diabetes Association | Q36081316 | ||
Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors | Q36111918 | ||
Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy | Q36431822 | ||
Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo | Q36431848 | ||
Diabetic neuropathy differs in type 1 and type 2 diabetes | Q36675877 | ||
Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications | Q37373683 | ||
Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice. | Q38302152 | ||
The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity. | Q38307297 | ||
Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. | Q39373122 | ||
Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst | Q39703468 | ||
Nicotinamide reverses neurological and neurovascular deficits in streptozotocin diabetic rats | Q39770678 | ||
Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice | Q40666489 | ||
Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation | Q42497877 | ||
Mechanisms of peroxynitrite decomposition catalyzed by FeTMPS, a bioactive sulfonated iron porphyrin | Q43616050 | ||
Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. | Q43687872 | ||
Effect of the hydroxyl radical scavenger, dimethylthiourea, on peripheral nerve tissue perfusion, conduction velocity and nociception in experimental diabetes | Q43763526 | ||
Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor | Q43794467 | ||
Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity | Q44220798 | ||
Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy | Q44262556 | ||
The spectrum of neuropathy in diabetes and impaired glucose tolerance | Q44276740 | ||
Sensory neurons with activated caspase-3 survive long-term experimental diabetes | Q44564049 | ||
Nitrosative stress in early Type 1 diabetes. David H. P. Streeten Memorial Lecture | Q44691959 | ||
P433 | issue | 6 | |
P921 | main subject | type-1 diabetes | Q124407 |
peripheral neuropathy | Q945238 | ||
P304 | page(s) | 783-792 | |
P577 | publication date | 2007-12-01 | |
P1433 | published in | International Journal of Molecular Medicine | Q6051492 |
P1476 | title | Evaluation of the peroxynitrite decomposition catalyst Fe(III) tetra-mesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetes | |
P478 | volume | 20 |
Q36858159 | Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis. |
Q36861641 | Anti-inflammatory mesenchymal stem cells (MSC2) attenuate symptoms of painful diabetic peripheral neuropathy |
Q42362780 | Association of myelinated primary afferents impairment with mechanical allodynia in diabetic peripheral neuropathy: an experimental study in rats |
Q34434392 | Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation. |
Q37598878 | Cardiac autonomic neuropathy in patients with diabetes mellitus. |
Q38053032 | Design, mechanism of action, bioavailability and therapeutic effects of mn porphyrin-based redox modulators. |
Q91762128 | Diabetic neuropathy research: from mouse models to targets for treatment |
Q37605348 | Diabetic painful and insensate neuropathy: pathogenesis and potential treatments |
Q34086993 | Different roles of 12/15-lipoxygenase in diabetic large and small fiber peripheral and autonomic neuropathies. |
Q33781251 | High-fat diet-induced neuropathy of prediabetes and obesity: effect of PMI-5011, an ethanolic extract of Artemisia dracunculus L |
Q35160501 | Impaired sensory nerve function and axon morphology in mice with diabetic neuropathy |
Q34603026 | Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes |
Q28397657 | Mechanisms of Peroxynitrite Interactions with Heme Proteins |
Q33874485 | New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha} |
Q34670046 | Nitrosylated proteins in monocytes as a new marker of oxidative-nitrosative stress in diabetic subjects with macroangiopathy. |
Q37373674 | Peripheral neuropathy in mice with neuronal nitric oxide synthase gene deficiency |
Q42391139 | Peroxynitrite Mediates Diabetes-Induced Endothelial Dysfunction: Possible Role of Rho Kinase Activation |
Q34257700 | Peroxynitrite and protein nitration in the pathogenesis of diabetic peripheral neuropathy. |
Q34314724 | Peroxynitrite-driven mechanisms in diabetes and insulin resistance - the latest advances |
Q35579658 | Phenotypic changes in diabetic neuropathy induced by a high-fat diet in diabetic C57BL/6 mice |
Q34667363 | Role of 12/15-lipoxygenase in nitrosative stress and peripheral prediabetic and diabetic neuropathies |
Q37230827 | Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction |
Q36734840 | Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease |
Q35854702 | Triglyceride, nonesterified fatty acids, and prediabetic neuropathy: role for oxidative-nitrosative stress |
Search more.